{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:10:48Z","timestamp":1790021448103,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["19-76-30014"],"award-info":[{"award-number":["19-76-30014"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clnesp.2026.105066","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:39:08Z","timestamp":1788190748000},"page":"105066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effect of sucrose-free brazzein-sweetened ice cream on continuously monitored glycemic response in patients with metabolic dysfunction-associated steatotic liver disease: A randomized controlled double-blind crossover trial"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4417-8076","authenticated-orcid":false,"given":"Vasily A.","family":"Isakov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir I.","family":"Pilipenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei A.","family":"Goncharov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armida","family":"Sasunova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2026.105066_bib1","article-title":"Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021","volume":"7","author":"Feng","year":"2025","journal-title":"JHEP Rep"},{"key":"10.1016\/j.clnesp.2026.105066_bib2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cld.2023.01.001","article-title":"Nonalcoholic fatty liver disease: disease burden and disease awareness","volume":"27","author":"Golabi","year":"2023","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clnesp.2026.105066_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/apt.18011","article-title":"Steatotic liver disease-associated all-cause\/Cause-specific mortality in the United States","volume":"60","author":"Kim","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clnesp.2026.105066_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12916-024-03366-3","article-title":"Hepatic steatosis, metabolic dysfunction and risk of mortality: findings from a multinational prospective cohort study","volume":"22","author":"Mayen","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.clnesp.2026.105066_bib5","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/HEP.0000000000000670","article-title":"Metabolic dysfunction\u2013associated steatotic liver disease: update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease","volume":"79","author":"Kanwal","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.clnesp.2026.105066_bib6","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jhep.2024.01.014","article-title":"Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease","volume":"80","author":"Younossi","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.clnesp.2026.105066_bib7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.clnesp.2026.105066_bib8","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"Tacke","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.clnesp.2026.105066_bib9","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.clnesp.2026.105066_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155835","article-title":"Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: trials, opportunities, and challenges","volume":"154","author":"Kokkorakis","year":"2024","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.clnesp.2026.105066_bib11","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/HEP.0000000000001608","article-title":"Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: november 2025 updates to AASLD Practice Guidance","volume":"83","author":"Bansal","year":"2026","journal-title":"Hepatology"},{"key":"10.1016\/j.clnesp.2026.105066_bib12","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","article-title":"Fructose and sugar: a major mediator of non-alcoholic fatty liver disease","volume":"68","author":"Jensen","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.clnesp.2026.105066_bib13","article-title":"Dietary pattern modifies the risk of MASLD through metabolomic signature","volume":"6","author":"Wu","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.clnesp.2026.105066_bib14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12944-025-02710-7","article-title":"Culturally adapted hypocaloric diet improves hepatic steatosis, inflammatory and oxidative biomarkers in Egyptian MASLD patients: a single-arm interventional study","volume":"24","author":"Elhoseeny","year":"2025","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.clnesp.2026.105066_bib15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4093\/dmj.2025.0026","article-title":"Assessing nutritional factors for metabolic dysfunction-associated steatotic liver disease via diverse statistical tools","volume":"50","author":"Lee","year":"2025","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.clnesp.2026.105066_bib16","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1017\/S1368980022001598","article-title":"Global trends in added sugars and non-nutritive sweetener use in the packaged food supply: drivers and implications for public health","volume":"26","author":"Russell","year":"2023","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.clnesp.2026.105066_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/bs7030044","article-title":"Strategies to improve adherence to dietary weight loss interventions in research and real-world settings","volume":"7","author":"Gibson","year":"2017","journal-title":"Behav Sci"},{"key":"10.1016\/j.clnesp.2026.105066_bib18","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.3390\/jcm10102208","article-title":"Influence of psychological biomarkers on therapeutic adherence by patients with non-alcoholic fatty liver disease: a moderated mediation model","volume":"10","author":"Funuyet-Salas","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.clnesp.2026.105066_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clnesp.2017.01.004","article-title":"The role of artificial and natural sweeteners in reducing the consumption of table sugar: a narrative review","volume":"18","author":"Mooradian","year":"2017","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.clnesp.2026.105066_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112243","article-title":"The relationship between anthropometric indices and cardiovascular risk in patients with type 2 diabetes mellitus","volume":"224","author":"Arslan","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.clnesp.2026.105066_bib21","doi-asserted-by":"crossref","first-page":"E929","DOI":"10.1503\/cmaj.161390","article-title":"Nonnutritive sweeteners and cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials and prospective cohort studies","volume":"189","author":"Azad","year":"2017","journal-title":"CMAJ (Can Med Assoc J)"},{"key":"10.1016\/j.clnesp.2026.105066_bib22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3390\/diseases13040115","article-title":"Artificial sweeteners: a double-edged sword for gut microbiome","volume":"13","author":"Hetta","year":"2025","journal-title":"Diseases"},{"key":"10.1016\/j.clnesp.2026.105066_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2023.112237","article-title":"Effect of low-and non-calorie sweeteners on the gut microbiota: a review of clinical trials and cross-sectional studies","volume":"117","author":"Gauthier","year":"2024","journal-title":"Nutrition"},{"key":"10.1016\/j.clnesp.2026.105066_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003950","article-title":"Artificial sweeteners and cancer risk: results from the NutriNet-Sante population-based cohort study","volume":"19","author":"Debras","year":"2022","journal-title":"PLoS Med"},{"key":"10.1016\/j.clnesp.2026.105066_bib25","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.3390\/foods12224065","article-title":"Sweet-tasting natural proteins brazzein and monellin: safe sugar substitutes for the food industry","volume":"12","author":"Novik","year":"2023","journal-title":"Foods"},{"key":"10.1016\/j.clnesp.2026.105066_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1475-2891-4-5","article-title":"Sweet proteins--potential replacement for artificial low calorie sweeteners","volume":"4","author":"Kant","year":"2005","journal-title":"Nutr J"},{"key":"10.1016\/j.clnesp.2026.105066_bib27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0014-5793(94)01184-2","article-title":"Brazzein, a new high-potency thermostable sweet protein from Pentadiplandra brazzeana B","volume":"355","author":"Ming","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.clnesp.2026.105066_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/foods12101943","article-title":"Brazzein and monellin: chemical analysis, food industry applications, safety and quality control, nutritional profile and health impacts","volume":"12","author":"Saraiva","year":"2023","journal-title":"Foods"},{"key":"10.1016\/j.clnesp.2026.105066_bib29","series-title":"GRN No.1142 Brazzein produced by Komagataella phaffii expressing a gene encoding for brazzein from Pentadiplandra brazzeana","author":"FDA","year":"2024"},{"key":"10.1016\/j.clnesp.2026.105066_bib30","series-title":"GRN No.1207 Brazzein preparation produced by Aspergillus oryzae 90402 expressing a gene encoding for brazzein from Pentadiplandra brazzeana","author":"FDA","year":"2025"},{"key":"10.1016\/j.clnesp.2026.105066_bib31","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1021\/acs.jafc.0c00317","article-title":"3M-Brazzein as a natural sugar substitute attenuates obesity, metabolic disorder, and inflammation","volume":"68","author":"Kim","year":"2020","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.clnesp.2026.105066_bib32","article-title":"Safety evaluation of oubli fruit sweet protein (brazzein) derived from Komagataella phaffii, intended for use as a sweetener in food and beverages","volume":"7","author":"Lynch","year":"2023","journal-title":"Toxicol Res Appl"},{"key":"10.1016\/j.clnesp.2026.105066_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1362529","article-title":"Effect of the consumption of brazzein and monellin, two recombinant sweet-tasting proteins, on rat gut microbiota","volume":"11","author":"Veselovsky","year":"2024","journal-title":"Front Nutr"},{"key":"10.1016\/j.clnesp.2026.105066_bib34","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2337\/dci24-0094","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in people with diabetes: the need for screening and early intervention. A consensus report of the American diabetes Association","volume":"48","author":"Cusi","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnesp.2026.105066_bib35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/dairy7030044","article-title":"Acceptability of Brazzein-Sweetened ice cream as a sugar-reduction strategy in Metabolic dysfunction-associated steatotic liver disease: a double-blind randomized crossover sensory study","volume":"7","author":"Isakov","year":"2026","journal-title":"Dairy"},{"key":"10.1016\/j.clnesp.2026.105066_bib36","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.clnesp.2026.105066_bib37","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jhep.2010.07.033","article-title":"Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy","volume":"54","author":"Tsochatzis","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.clnesp.2026.105066_bib38","doi-asserted-by":"crossref","DOI":"10.1177\/11786388221076962","article-title":"Sugar-free dark chocolate consumption results in lower blood glucose in adults with diabetes","volume":"15","author":"Oliveira","year":"2022","journal-title":"Nutr Metab Insights"},{"key":"10.1016\/j.clnesp.2026.105066_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/foods13060920","article-title":"Effect of sugar-free jelly on glycemic metabolism and its potential health benefits in non-diabetic adults","volume":"13","author":"Han","year":"2024","journal-title":"Foods"},{"key":"10.1016\/j.clnesp.2026.105066_bib40","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s00394-017-1409-z","article-title":"Replacement of glycaemic carbohydrates by inulin-type fructans from chicory (oligofructose, inulin) reduces the postprandial blood glucose and insulin response to foods: report of two double-blind, randomized, controlled trials","volume":"57","author":"Lightowler","year":"2018","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.clnesp.2026.105066_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2021.102354","article-title":"Pre-meal high-performance inulin supplementation reduce post-prandial glycaemic response in healthy subjects: a repeated single-arm clinical trial","volume":"16","author":"Wijaya","year":"2022","journal-title":"Diabetes Metabol Syndr"},{"key":"10.1016\/j.clnesp.2026.105066_bib42","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/ajcn\/nqaa167","article-title":"Acute glycemic and insulinemic effects of low-energy sweeteners: a systematic review and meta-analysis of randomized controlled trials","volume":"112","author":"Greyling","year":"2020","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnesp.2026.105066_bib43","article-title":"The effect of non-nutritive sweetened beverages on postprandial glycemic and endocrine responses: a systematic review and network meta-analysis","volume":"15","author":"Zhang","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2026.105066_bib44","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00125-004-1342-6","article-title":"Incretins, insulin secretion and type 2 diabetes mellitus","volume":"47","author":"Vilsboll","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnesp.2026.105066_bib45","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1007\/s00125-023-05956-x","article-title":"Incretin hormones and type 2 diabetes","volume":"66","author":"Nauck","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnesp.2026.105066_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/gels8100642","article-title":"Intake of sugar substitute gummy candies benefits the glycemic response in healthy adults: a prospective crossover clinical trial","volume":"8","author":"Gan","year":"2022","journal-title":"Gels"},{"key":"10.1016\/j.clnesp.2026.105066_bib47","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2337\/db08-0063","article-title":"Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients","volume":"57","author":"Ceriello","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.clnesp.2026.105066_bib48","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/flgastro-2025-103183","article-title":"Nutrition in MASLD: a patient focused, evidence-based clinician\u2019s guide","volume":"17","author":"Pekarska","year":"2026","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.clnesp.2026.105066_bib49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s13679-024-00597-6","article-title":"Nutritional strategies for battling obesity-linked liver disease: the role of medical nutritional therapy in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) management","volume":"14","author":"Simancas-Racines","year":"2025","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.clnesp.2026.105066_bib50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ajcnut.2024.06.006","article-title":"The impact of short-term eucaloric low- and high-carbohydrate diets on liver triacylglycerol content in males with overweight and obesity: a randomized crossover study","volume":"120","author":"London","year":"2024","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnesp.2026.105066_bib51","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.3390\/nu16101408","article-title":"Gender differences in liver steatosis and fibrosis in overweight and Obese patients with metabolic dysfunction-associated steatotic liver disease before and after 8 weeks of very low-calorie Ketogenic diet","volume":"16","author":"Rinaldi","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2026.105066_bib52","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1210\/clinem\/dgaf382","article-title":"Effects of acute Iso- and hypocaloric carbohydrate restriction on liver fat and glucose and lipid metabolism","volume":"111","author":"London","year":"2026","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457726021637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457726021637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:23:01Z","timestamp":1790018581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457726021637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":52,"alternative-id":["S2405457726021637"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2026.105066","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of sucrose-free brazzein-sweetened ice cream on continuously monitored glycemic response in patients with metabolic dysfunction-associated steatotic liver disease: A randomized controlled double-blind crossover trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2026.105066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105066"}}